289 related articles for article (PubMed ID: 31074115)
1. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
Brunson A; Keegan T; Mahajan A; White R; Wun T
Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T
Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery.
Osei SK; Long GW; Sharrak A; Derias N; Goodson R; Callahan RE; Studzinski DM; Brown OW
J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):543-552. PubMed ID: 36574902
[TBL] [Abstract][Full Text] [Related]
5. Risk and complications of venous thromboembolism in dialysis patients.
Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.
Woods GM; Sharma R; Creary S; O'Brien S; Stanek J; Hor K; Young J; Dunn AL; Kumar R
J Pediatr; 2018 Jun; 197():186-190.e1. PubMed ID: 29605397
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
8. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton DH; Monreal Bosch M; Amendola M; Wolfe L; Perez Ductor C; Lecumberri R; Levy MM;
J Vasc Surg Venous Lymphat Disord; 2017 Jan; 5(1):18-24.e1. PubMed ID: 27987605
[TBL] [Abstract][Full Text] [Related]
9. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma.
Mahajan A; Brunson A; Keegan THM; Rosenberg A; Wun T
Leuk Lymphoma; 2020 Nov; 61(11):2605-2613. PubMed ID: 32573292
[TBL] [Abstract][Full Text] [Related]
10. Bleeding in patients with sickle cell disease: a population-based study.
Hariharan N; Brunson A; Mahajan A; Keegan THM; Wun T
Blood Adv; 2020 Mar; 4(5):793-802. PubMed ID: 32108229
[TBL] [Abstract][Full Text] [Related]
11. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
Patel A; Williams H; Baer MR; Zimrin AB; Law JY
Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
[TBL] [Abstract][Full Text] [Related]
12. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
13. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis.
El-Amin N; Iness A; Cyrus JW; Sisler I; Karam O
Ann Hematol; 2022 Sep; 101(9):1931-1940. PubMed ID: 35895101
[TBL] [Abstract][Full Text] [Related]
15. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
Chee CE; Ashrani AA; Marks RS; Petterson TM; Bailey KR; Melton LJ; Heit JA
Blood; 2014 Jun; 123(25):3972-8. PubMed ID: 24782507
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
Naik RP; Streiff MB; Lanzkron S
J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
[TBL] [Abstract][Full Text] [Related]
17. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
Piran S; Schulman S
Thromb Res; 2016 Nov; 147():97-101. PubMed ID: 27721141
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.
Alvarez-Alvarez RJ; Barge-Caballero E; Chavez-Leal SA; Paniagua-Martin MJ; Marzoa-Rivas R; Caamaño CB; López-Sainz Á; Grille-Cancela Z; Blanco-Canosa P; Herrera-Noreña JM; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
J Heart Lung Transplant; 2015 Feb; 34(2):167-74. PubMed ID: 25434523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
